Xinrong Yang

ORCID：0009-0009-9258-312X

发表论文 5 篇 · 总被引 53 次 · h-index 2

代表论文

• Anlotinib plus penpulimab versus sorafenib in the first-line treatment of unresectable hepatocellular carcinoma (APOLLO): a randomised, controlled, phase 3 trial (2025 · The Lancet Oncology · 被引 49)
• Role of Lactobacillus in cervical cancer (2018 · DOAJ (DOAJ: Directory of Open Access Journals) · 被引 4)
• ZD-4009, a Novel BCL9 Inhibitor, Is Associated with Ameliorated Pulmonary Fibrosis and Reduced HIF-1α-Mediated Glycolysis and TGF-β/SMAD Signaling (2026 · Molecular Pharmacology)
• Research on Prostate Cancer Pathological Image Classification Method Based on Vision Transformer (2024 · Lecture notes in electrical engineering)
• Efficacy of the Preoperative Albumin–Bilirubin Grade for Predicting Survival and Outcomes of Postoperative Chemotherapy for Advanced Gastric Cancer (2020 · DOAJ (DOAJ: Directory of Open Access Journals))